Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $81,979.59 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Free Report) insider Robert L. Scavo sold 5,313 shares of the business’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $15.43, for a total transaction of $81,979.59. Following the transaction, the insider now owns 668,106 shares in the company, valued at $10,308,875.58. The trade was a 0.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $15.79 on Friday. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $16.25. The company has a fifty day simple moving average of $14.38 and a two-hundred day simple moving average of $12.43. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market cap of $3.03 billion, a price-to-earnings ratio of -20.51 and a beta of 1.49.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. R Squared Ltd acquired a new stake in shares of Alignment Healthcare in the 4th quarter valued at $55,000. RiverPark Advisors LLC purchased a new position in Alignment Healthcare in the fourth quarter valued at $106,000. Tower Research Capital LLC TRC raised its stake in Alignment Healthcare by 146.7% in the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after buying an additional 6,286 shares in the last quarter. Ballentine Partners LLC purchased a new stake in Alignment Healthcare during the 4th quarter worth about $121,000. Finally, Aigen Investment Management LP acquired a new position in shares of Alignment Healthcare during the 4th quarter worth about $129,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ALHC. Piper Sandler upped their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, March 4th. Stifel Nicolaus upped their target price on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, February 28th. JPMorgan Chase & Co. lifted their price target on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Bank of America upped their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. Finally, William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

Check Out Our Latest Stock Report on ALHC

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Recommended Stories

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.